Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CL.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CL.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CL.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBF.8.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBF.8.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.8.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAUNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAUNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAUNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAY.1.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAY.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.1.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.25.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.25.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.25.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XADNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XADNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XADNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XABNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XABNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XABNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FT.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FT.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FT.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XALNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XALNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XALNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBWNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBWNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBWNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.3.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAY.1.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAY.1.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.1.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GY.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GY.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GY.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBF.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBF.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used